Trial Profile
Effect of imatinib in children and adolescent patients with chronic phase chronic myeloid leukemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 May 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 20 May 2015 New trial record